Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)
一项多中心回顾性队列研究,探讨抗体药物偶联物(ADC)曲妥珠单抗德鲁西替康(T-DXd)和沙妥珠单抗戈维替康(SG)在HER2低表达转移性乳腺癌(MBC)患者中的序贯应用。
期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-025-00748-5
Huppert, Laura A; Mahtani, Reshma; Fisch, Samantha; Dempsey, Naomi; Premji, Sarah; Raimonde, Angelina; Jacob, Saya; Quintal, Laura; Melisko, Michelle; Chien, Jo; Sandoval, Ana; Carcas, Lauren; Ahluwalia, Manmeet; Harpalani, Natasha; Hoppenworth, Jenna; Blaes, Anne; Blum, Kelly; Kim, Mi-Ok; Idossa, Dame; Rao, Ruta; Giridhar, Karthik V; Rugo, Hope S